Principal Investigator
Juan Alderuccio
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240458
Clinical Trial Summary
Zanubrutinib in Combination with Pola-R-CHP and High-dose
Methotrexate in Patients with Secondary CNS Lymphoma
Phase
Phase I
Funding Agency/Sponsor
Institutional
Disease
Lymphoma
Contact Information
Phone Number
+1 (305) 2434624